The 26 analysts offering 12-month price forecasts for Boston Scientific Corp have a median target of 52.00, with a high estimate of 57.00 and a low estimate of 45.00. The median estimate represents a +25.18% increase from the last price of 41.54.
The current consensus among 30 polled investment analysts is to Buy stock in Boston Scientific Corp. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.44
Reporting Date Feb 02
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.